Russia's R-Pharm secures approval of coronavir for outpatients
MOSCOW (Reuters) - Russia's R-Pharm on Friday announced the approval of coronavir for outpatient treatment of mild to moderate COVID-19 coronavirus infection, it said in a statement.
Coronavir, manufactured at R-Pharm's facility in Yaroslavl, will be available in pharmacies, the company added without elaborating.
(Writing by Katya Golubkova; Editing by David Goodman)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.